Profile and management pediatric brain tumors

Excerpt:


J Pharm Pharmacogn Res 9(5): 663-667, 2021. Original article Profile and management of pediatric brain tumors: A single–center experience [Perfil y tratamiento de los tumores cerebrales pediátricos: una experiencia de un solo centro] Nhu Hiep Pham1, Huu Son Nguyen2, Kiem Hao Tran2, Nguyen Cuong Pham3* 1Oncology Center, Hue Central Hospital, Hue city, Vietnam. 2Pediatric Center, Hue Central … Continue reading Profile and management pediatric brain tumors


J Pharm Pharmacogn Res 9(5): 663-667, 2021.

Original article

Profile and management of pediatric brain tumors: A single–center experience

[Perfil y tratamiento de los tumores cerebrales pediátricos: una experiencia de un solo centro]

Nhu Hiep Pham1, Huu Son Nguyen2, Kiem Hao Tran2, Nguyen Cuong Pham3*

1Oncology Center, Hue Central Hospital, Hue city, Vietnam.

2Pediatric Center, Hue Central Hospital, Hue city, Vietnam.

3Pathology Department, Hue Central Hospital, Hue city, Vietnam.

*E-mail: bscuonggpb@gmail.com

Abstract

Context: Pediatric brain tumors are the most common solid tumors and the leading cause of death among children worldwide. Although there are some published studies from many countries regarding the pathological model of pediatric brain tumors, comprehensive clinical pathology studies conducted at Vietnam are still lacking.

Aims: To explore the clinical and histopathological features of pediatric brain tumors at a central hospital in Vietnam.

Methods: This study used a retrospective epidemiological approach. Children aged <17 years were selected according to their profiles registered in our department during 2016–2020 when they were diagnosed with primary brain tumors. Data of patients’ age, sex, clinical features, and histology were collected. The 2016 World Health Organization classification of tumors was adopted.

Results: A total of 34 patients with brain tumors were identified, with a males/females ratio of 2.8/1. Patients’ age ranged from 3 months to 16 years, with a median age of 6 years. The most common presentation of brain tumor in our series was headache (47.1%). According to the location of involvement, 51.5% of the tumors were in supratentorial region. Moreover, astrocytes (55.9%) were the most common type of pediatric brain tumors. Surgery was the main treatment, and chemotherapy was administered to 14.7% of patients.

Conclusions: This study addresses the issue of sensitivity but not that of specificity of clinical features to the presence of an underlying brain tumor. Histopathology analysis is necessary to develop further treatment after neurosurgery.

Keywords: brain tumor; childhood; clinical features; pathology.

This image has an empty alt attribute; its file name is jppres_pdf_free.png
Resumen

Contexto: Los tumores cerebrales pediátricos son los tumores sólidos más comunes y la principal causa de muerte entre los niños en todo el mundo. Aunque existen algunos estudios publicados de muchos países sobre el modelo patológico de los tumores cerebrales pediátricos, todavía faltan estudios completos de patología clínica realizados en Vietnam.

Objetivos: Explorar las características clínicas e histopatológicas de los tumores cerebrales pediátricos en un hospital central de Vietnam.

Métodos: Este estudio utilizó un enfoque epidemiológico retrospectivo. Los niños menores de 17 años fueron seleccionados según sus perfiles registrados en nuestro servicio durante el período 2016-2020 cuando fueron diagnosticados de tumores cerebrales primarios. Se recopilaron datos de la edad, el sexo, las características clínicas y la histología de los pacientes. Se adoptó la clasificación de tumores de la Organización Mundial de la Salud de 2016.

Resultados: Se identificaron un total de 34 pacientes con tumores cerebrales, con una relación hombres/mujeres de 2,8/1. La edad de los pacientes varió de 3 meses a 16 años, con una mediana de edad de 6 años. La presentación más frecuente de tumor cerebral en nuestra serie fue la cefalea (47,1%). Según la localización de la afectación, el 51,5% de los tumores se encontraban en región supratentorial. Además, los astrocitos (55,9%) fueron el tipo más común de tumores cerebrales pediátricos. La cirugía fue el tratamiento principal y se administró quimioterapia al 14,7% de los pacientes.

Conclusiones: Este estudio aborda el tema de la sensibilidad pero no el de la especificidad de las características clínicas a la presencia de un tumor cerebral subyacente. El análisis histopatológico es necesario para desarrollar un tratamiento posterior después de la neurocirugía.

Palabras Clave: características clínicas; infancia; patología; tumor cerebral.

This image has an empty alt attribute; its file name is jppres_pdf_free.png
Citation Format: Pham NH, Nguyen HS, Tran KH, Pham NC (2021) Profile and management of pediatric brain tumors: A single–center experience. J Pharm Pharmacogn Res 9(5): 663–667.

© 2021 Journal of Pharmacy & Pharmacognosy Research (JPPRes)

Toxicity evaluation of Ruta angustifolia leaves ethanolic extract
J. Pharm. Pharmacogn. Res., vol. 11, no. 3, pp. 437-447, May-June 2023. DOI: https://doi.org/10.56499/jppres23.1609_11.3.437 Original Article Acute and repeated dose 28-day oral toxicity of Ruta angustifolia Pers. leaves ethanolic extract in Wistar rats [Toxicidad oral aguda y por dosis repetidas durante 28 días del extracto etanólico de hojas de Ruta angustifolia Pers. en ratas Wistar] Tutik … Continue reading Toxicity evaluation of Ruta angustifolia leaves ethanolic extract
Adolescents in Indonesia and COVID-19 pandemic
J. Pharm. Pharmacogn. Res., vol. 11, no. 3, pp. 426-436, May-June 2023. DOI: https://doi.org/10.56499/jppres22.1560_11.3.426 Original Article Perception, mental health, and social media exposure on adolescents in Indonesia during COVID-19 pandemic [Percepción, salud mental y exposición a los medios sociales en adolescentes de Indonesia durante la pandemia de COVID-19] Efa Nugroho1*, Alfiana Ainun Nisa1, Widya Hary Cahyati1, … Continue reading Adolescents in Indonesia and COVID-19 pandemic
Decaffeinated green tea and coffee extracts and metabolic syndrome
J. Pharm. Pharmacogn. Res., vol. 11, no. 3, pp. 414-425, May-June 2023. DOI: https://doi.org/10.56499/jppres23.1593_11.3.414 Original Article Decaffeinated green tea and green coffee extracts as metformin’s add-on enhance metabolic syndrome risk factors and improve the cardiac insulin-gene-related pathway [Extractos de té verde y café verde descafeinados como complemento de la metformina mejoran los factores de riesgo del … Continue reading Decaffeinated green tea and coffee extracts and metabolic syndrome

© 2013-2020 by the authors; licensee JPPRes, Antofagasta, Chile. This journal is an open-access journal distributed under the terms and conditions of the Creative Commons Attribution license-Non Commercial 4.0 international. The content on this site is intended for health professionals. If you are not a health professional, please talk to your doctor about any doubts or concerns regarding your health

Made with ♥ by AVAGAX Studio